Integrating pharmacogenomics- metabolomics towards realising personalised medicine for colorectal cancer patients treated with 5-fluorouracil / Hazwanie Hashim
Colorectal cancer (CRC) is one of the most common cancers among men and women in Malaysia. 5-flurouracil (5-FU)/leucovorin is the standard chemotherapy for colorectal cancer and various other types of cancer including breast, head and neck cancers. However, standard method for dosing 5-fluorouracil...
Saved in:
Main Author: | Hashim, Hazwanie |
---|---|
Format: | Book Section |
Language: | English |
Published: |
Institute of Graduate Studies, UiTM
2012
|
Subjects: | |
Online Access: | http://ir.uitm.edu.my/id/eprint/19122/1/ABS_HAZWANIE%20HASHIM%20TDRA%20VOL%201%20IGS%2012.pdf http://ir.uitm.edu.my/id/eprint/19122/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metabolomics and pharmacogenetics based 5-fluorouracil monitoring in colorectal cancer patients
by: Zakaria, Bannur, et al.
Published: (2014) -
Potential of dihydropyrimidine dehydrogenase genotypes in personalising 5-fluorouracil therapy among colorectal cancer patients
by: Ngow, Harris Abdullah, et al.
Published: (2011) -
Metabolomics and pharmacogenetics based 5-fluorouracil monitoring in colorectal cancer patients
by: Bannur, Zakaria, et al.
Published: (2014) -
Potential of dihydropyrimidine dehydrogenase genotypes in personalizing 5-fluorouracil therapy among colorectal cancer patients
by: Teh, Lay Kek, et al.
Published: (2013) -
Metabolomics profiling of serum samples of Malaysian patients with colorectal cancer / Nurul Azmir Amir Hashim
by: Amir Hashim, Nurul Azmir
Published: (2021)